Emerging implications of bacterial biofilm in cancer biology: Recent updates and major perspectives

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Flemming H-C, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016;14(9):563–575. doi:10.1038/nrmicro.2016.94.
   PubMed Web of Science ®Google Scholar
• Mirzaei R, Abdi M, Gholami H. The host metabolism following bacterial biofilm: what is the mechanism of action? Rev Med Microbiol. 2020;31(4):175–182. doi:10.1097/MRM.0000000000000216.
   Web of Science ®Google Scholar
• Mirzaei R, Mohammadzadeh R, Sholeh M, Karampoor S, Abdi M, Dogan E, Moghadam MS, Kazemi S, Jalalifar S, Dalir A, et al. The importance of intracellular bacterial biofilm in infectious diseases. Microb Pathog. 2020;147:104393. doi:10.1016/j.micpath.2020.104393.
   PubMed Web of Science ®Google Scholar
• Koo H, Yamada KM. Dynamic cell–matrix interactions modulate microbial biofilm and tissue 3D microenvironments. Curr Opin Cell Biol. 2016;42:102–112. doi:10.1016/j.ceb.2016.05.005.
   PubMed Web of Science ®Google Scholar
• Akyıldız İ, Take G, Uygur K, Kızıl Y, Aydil U. Bacterial biofilm formation in the middle-ear mucosa of chronic otitis media patients. Indian J Otolaryngol Head Neck Surg. 2013;65(S3):557–561. doi:10.1007/s12070-012-0513-x.
   PubMedGoogle Scholar
• Masters EA, Trombetta RP, De Mesy Bentley KL, Boyce BF, Gill AL, Gill SR, Nishitani K, Ishikawa M, Morita Y, Ito H, et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy. Bone Res. 2019;7:20. doi:10.1038/s41413-019-0061-z.
   PubMed Web of Science ®Google Scholar
• Southey-Pillig CJ, Davies DG, Sauer K. Characterization of temporal protein production inPseudomonas aeruginosa Biofilms. Biofilms J Bacteriol. 2005;187(23):8114–8126. doi:10.1128/JB.187.23.8114-8126.2005.
   PubMed Web of Science ®Google Scholar
• Machado A, Cerca N. Influence of biofilm formation by Gardnerella vaginalis and other anaerobes on bacterial vaginosis. J Infect Dis. 2015;212(12):1856–1861. doi:10.1093/infdis/jiv338.
   PubMed Web of Science ®Google Scholar
• Von Rosenvinge EC, GA O, Macfarlane S, Macfarlane GT, Shirtliff ME. Microbial biofilms and gastrointestinal diseases. Pathogens Disease. 2013;67:25–38. doi:10.1111/2049-632X.12020.
   PubMed Web of Science ®Google Scholar
• Behlau I, Gilmore MS. Microbial biofilms in ophthalmology and infectious disease. Archives of Ophthalmology. 2008;126(11):1572 doi:10.1001/archopht.126.11.1572.
   Google Scholar
• Vieira Colombo AP, Magalhães CB, FARR H, Martins Do Souto R, Maciel Da Silva-Boghossian C. Periodontal-disease-associated biofilm: a reservoir for pathogens of medical importance. Microb Pathog. 2016;94:27–34. doi:10.1016/j.micpath.2015.09.009.
   PubMed Web of Science ®Google Scholar
• Delcaru C, Alexandru I, Podgoreanu P, Grosu M, Stavropoulos E, Chifiriuc M, Lazar V. Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens. 2016;5(4):65. doi:10.3390/pathogens5040065.
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322. doi:10.1126/science.284.5418.1318.
   PubMed Web of Science ®Google Scholar
• Sharma D, Misba L, Khan AU. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control. 2019;8(1):76. doi:10.1186/s13756-019-0533-3.
   PubMed Web of Science ®Google Scholar
• Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J. Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics. 2021;10:3. doi:10.3390/antibiotics10010003.
   Google Scholar
• Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, DeStefano Shields CE, Hechenbleikner EM, Huso DL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359(6375):592–597. doi:10.1126/science.aah3648.
   PubMed Web of Science ®Google Scholar
• Martinez-Medina M, Naves P, Blanco J, Aldeguer X, Blanco JE, Blanco M, Ponte C, Soriano F, Darfeuille-Michaud A, Garcia-Gil LJ. Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli(AIEC). BMC Microbiol. 2009;9:202. doi:10.1186/1471-2180-9-202.
   PubMed Web of Science ®Google Scholar
• Prudent V, Demarre G, Vazeille E, Wery M, Quenech’du N, Ravet A, Dauverd - Girault J, van Dijk E, Bringer M-A, Descrimes M, et al. The Crohn’s disease-related bacterial strain LF82 assembles biofilm-like communities to protect itself from phagolysosomal attack. Commun Biol. 2021;4(1):1–13. doi:10.1038/s42003-021-02161-7.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43(7):3380–3389. doi:10.1128/JCM.43.7.3380-3389.2005.
   PubMed Web of Science ®Google Scholar
• Weng J, Li S, Zhu Z, Liu Q, Zhang R, Yang Y, Li X. Exploring immunotherapy in colorectal cancer. J Hematol Oncol. 2022;15(1):95. doi:10.1186/s13045-022-01294-4.
   PubMed Web of Science ®Google Scholar
• Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol. 2002;56(1):187–209. doi:10.1146/annurev.micro.56.012302.160705.
   PubMed Web of Science ®Google Scholar
• Vestby LK, Grønseth T, Simm R, Nesse LL. Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics. 2020;9(2):59. doi:10.3390/antibiotics9020059.
   Web of Science ®Google Scholar
• Al-Hilu SA, Al-Shujairi WH. Dual role of bacteria in carcinoma: stimulation and inhibition. Iran J Pediatr Hematol Oncol. 2020;2020:e4639761. doi:10.1155/2020/4639761.
   Google Scholar
• Rizzato C, Torres J, Kasamatsu E, Camorlinga-Ponce M, Bravo MM, Canzian F, Kato I. Potential role of biofilm formation in the development of digestive tract cancer with special reference to helicobacter pylori infection. Front Microbiol. 2019;10:846. doi:10.3389/fmicb.2019.00846.
   PubMed Web of Science ®Google Scholar
• Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014;20(4):859–867. doi:10.1158/1078-0432.CCR-13-1343.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ling Z, Li L. The intestinal microbiota and colorectal cancer. Front Immunol [Internet]. 2020;11. doi:10.3389/fimmu.2020.615056.
   Web of Science ®Google Scholar
• Shukla R, Shukla P, Behari A, Khetan D, Chaudhary RK, Tsuchiya Y, Ikoma T, Asai T, Nakamura K, Kapoor VK. Roles of Salmonella typhi and Salmonella paratyphi in gallbladder cancer development. Asian Pac J Cancer Prev. 2021;22(2):509–516. doi:10.31557/APJCP.2021.22.2.509.
   PubMedGoogle Scholar
• Tian Y, Hao T, Cao B, Zhang W, Ma Y, Lin Q, Li X. Clinical end-points associated with mycobacterium tuberculosis and lung cancer: implications into host-pathogen interaction and coevolution. Biomed Res Int. 2015;2015:827829. doi:10.1155/2015/827829.
   PubMed Web of Science ®Google Scholar
• Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Abnet CC, Stolzenberg-Solomon R, Miller G, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut. 2018;67(1):120–127. doi:10.1136/gutjnl-2016-312580.
   PubMed Web of Science ®Google Scholar
• Jacob JA. Study links periodontal disease bacteria to pancreatic cancer risk. JAMA. 2016;315(24):2653. doi:10.1001/jama.2016.6295.
   PubMed Web of Science ®Google Scholar
• Boleij A, Schaeps RMJ, Tjalsma H. Association Between streptococcus bovis and colon cancer. J Clin Microbiol. 2009;47(2):516. doi:10.1128/JCM.01755-08.
   PubMed Web of Science ®Google Scholar
• Zarkin BA, Lillemoe KD, Cameron JL, Effron PN, Magnuson TH, Pitt HA. The triad of streptococcus bovis bacteremia, colonic pathology, and liver disease: annals of surgery. Annals Of Surgery. 1990;211(6):786. doi:10.1097/00000658-199006000-00019.
   PubMed Web of Science ®Google Scholar
• Tateda M, Shiga K, Saijo S, Sone M, Hori T, Yokoyama J, Matsuura K, Takasaka T, Miyagi T. Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med [Internet]. 2000. [accessed 2023 Aug 16]. doi:10.3892/ijmm.6.6.699.
   PubMed Web of Science ®Google Scholar
• Gopinath D, Wie CC, Banerjee M, Thangavelu L, Kumar RP, Nallaswamy D, Botelho MG, Johnson NW. Compositional profile of mucosal bacteriome of smokers and smokeless tobacco users. Clin Oral Invest. 2022;26(2):1647–1656. doi:10.1007/s00784-021-04137-7.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Liu X, Yang Q, Chen L, Yang D. Salivary microbiome in adenoid cystic carcinoma detected by 16s rRNA sequencing and shotgun metagenomics. Front Cell Infect Microbiol. 2021;11:774453. doi:10.3389/fcimb.2021.774453.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Miyajima S, Okada N. Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren’s syndrome. J Dermatol. 2000;27(7):450–452. doi:10.1111/j.1346-8138.2000.tb02204.x.
   PubMedGoogle Scholar
• Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151(4):363–374. doi:10.1111/imm.12760.
   PubMed Web of Science ®Google Scholar
• Sharma G, Garg N, Hasan S, Shirodkar S. Prevotella: an insight into its characteristics and associated virulence factors. Microb Pathog. 2022;169:105673. doi:10.1016/j.micpath.2022.105673.
   PubMed Web of Science ®Google Scholar
• Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, Peterson SN, Snesrud EC, Borisy GG, Lazarev M, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Nat Acad Sci 2014; 111:18321–18326.
   PubMed Web of Science ®Google Scholar
• de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Global Health. 2020;8:e180–90. doi:10.1016/S2214-109X(19)30488-7.
   PubMed Web of Science ®Google Scholar
• Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy. CA Cancer J Clin. 2017;67(4):326–344. doi:10.3322/caac.21398.
   PubMed Web of Science ®Google Scholar
• Ellermann M, Sartor RB. Intestinal bacterial biofilms modulate mucosal immune responses. J Immunol Sci. 2018;2:13–18. doi:10.29245/2578-3009/2018/2.1122.
   PubMedGoogle Scholar
• Otto M. Staphylococcus epidermidis–the “accidental” pathogen. Nat Rev Microbiol. 2009;7:555–567. doi:10.1038/nrmicro2182.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi:10.1016/j.chom.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Ciernikova S, Sevcikova A, Stevurkova V, Mego M. Tumor microbiome - an integral part of the tumor microenvironment. Front Oncol. 2022;12:1063100. doi:10.3389/fonc.2022.1063100.
   PubMed Web of Science ®Google Scholar
• Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer Cell. 2021;39(10):1317–1341. doi:10.1016/j.ccell.2021.08.006.
   PubMed Web of Science ®Google Scholar
• Upadhyay A, Pal D, Kumar A. Substantial relation between the bacterial biofilm and oncogenesis progression in host. Microb Pathog. 2023;175:105966. doi:10.1016/j.micpath.2022.105966.
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Larsson JMH, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions. Proc Natl Acad Sci USA. 2011;108(supplement_1):4659–4665. doi:10.1073/pnas.1006451107.
   PubMedGoogle Scholar
• Johansson MEV, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63(2):281–291. doi:10.1136/gutjnl-2012-303207.
   PubMed Web of Science ®Google Scholar
• Mirzaei R, Sabokroo N, Ahmadyousefi Y, Motamedi H, Karampoor S. Immunometabolism in biofilm infection: lessons from cancer. Mol Med. 2022;28(1):10. doi:10.1186/s10020-022-00435-2.
   PubMed Web of Science ®Google Scholar
• Römling U, Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med. 2012;272(6):541–561. doi:10.1111/joim.12004.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789. doi:10.1002/ijc.33588.
   Web of Science ®Google Scholar
• Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018;119(7):785–792. doi:10.1038/s41416-018-0264-x.
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0.
   PubMed Web of Science ®Google Scholar
• Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009;29:2727–2737.
   PubMed Web of Science ®Google Scholar
• den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325–2340. doi:10.1194/jlr.R036012.
   PubMed Web of Science ®Google Scholar
• Natividad JMM, Verdu EF. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res. 2013;1:42–51. doi:10.1016/j.phrs.2012.10.007.
   Google Scholar
• Bäumler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535(7610):85–93. doi:10.1038/nature18849.
   PubMed Web of Science ®Google Scholar
• Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539–544. doi:10.1126/science.aad9378.
   PubMed Web of Science ®Google Scholar
• Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25(3):377–388. doi:10.1038/s41591-019-0377-7.
   PubMed Web of Science ®Google Scholar
• Li S, Liu J, Zheng X, Ren L, Yang Y, Li W, Fu W, Wang J, Du G. Tumorigenic bacteria in colorectal cancer: mechanisms and treatments. Cancer Biol Med. 2022;19:147–162.
   Web of Science ®Google Scholar
• White MT, Sears CL. The microbial landscape of colorectal cancer. Nat Rev Microbiol [Internet]. 2023. [accessed 2023 Dec 6]. https://www.nature.com/articles/s41579-023-00973-4.
   PubMed Web of Science ®Google Scholar
• Hernández-Luna MA, López-Briones S, Luria-Pérez R. The four horsemen in colon cancer. J Oncol. 2019;2019:1–12. doi:10.1155/2019/5636272.
   Web of Science ®Google Scholar
• Dalal N, Jalandra R, Bayal N, Yadav AK, Harshulika N, Sharma M, Makharia GK, Kumar P, Singh R, Solanki PR, et al. Gut microbiota-derived metabolites in CRC progression and causation. J Cancer Res Clin Oncol. 2021;147:3141–3155. doi:10.1007/s00432-021-03729-w.
   Web of Science ®Google Scholar
• Jalandra R, Dalal N, Yadav AK, Verma D, Sharma M, Singh R, Khosla A, Kumar A, Solanki PR. Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer. Appl Microbiol Biotechnol. 2021;105(20):7651–7660. doi:10.1007/s00253-021-11582-7.
   PubMed Web of Science ®Google Scholar
• Silva CL, Olival A, Perestrelo R, Silva P, Tomás H, Câmara JS. Untargeted Urinary 1H NMR-Based metabolomic pattern as a potential platform in breast cancer detection. Metabolites. 2019;9(11):269. doi:10.3390/metabo9110269.
   PubMed Web of Science ®Google Scholar
• Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng T-Y, et al. Plasma choline metabolites and colorectal cancer risk in the women’s health initiative observational study. Cancer Res. 2014;74(24):7442–7452. doi:10.1158/0008-5472.CAN-14-1835.
   PubMed Web of Science ®Google Scholar
• Janeiro MH, Ramírez MJ, Milagro FI, Martínez JA, Solas M. Implication of trimethylamine N-Oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients. 2018;10(10):1398. doi:10.3390/nu10101398.
   PubMed Web of Science ®Google Scholar
• Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585–1595. doi:10.1016/j.cell.2015.11.055.
   PubMed Web of Science ®Google Scholar
• Nougayrède J-P, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848–851. doi:10.1126/science.1127059.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, Lochs H. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998;115(2):281–286. doi:10.1016/S0016-5085(98)70194-5.
   PubMed Web of Science ®Google Scholar
• Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC, et al. The bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis. 2015;60(2):208–215. doi:10.1093/cid/ciu787.
   PubMed Web of Science ®Google Scholar
• Chung L, Thiele Orberg E, Geis AL, Chan JL, Fu K, DeStefano Shields CE, Dejea CM, Fathi P, Chen J, Finard BB, et al. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host Microbe. 2018;23(2):203–214.e5. doi:10.1016/j.chom.2018.01.007.
   PubMed Web of Science ®Google Scholar
• Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299–306. doi:10.1101/gr.126516.111.
   PubMed Web of Science ®Google Scholar
• Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679–689. doi:10.1038/s41591-019-0406-6.
   PubMed Web of Science ®Google Scholar
• Abdulamir AS, Hafidh RR, Bakar FA. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res. 2011;30(1):11. doi:10.1186/1756-9966-30-11.
   PubMed Web of Science ®Google Scholar
• Aymeric L, Donnadieu F, Mulet C, du Merle L, Nigro G, Saffarian A, Bérard M, Poyart C, Robine S, Regnault B, et al. Colorectal cancer specific conditions promote streptococcus gallolyticus gut colonization. Proc Natl Acad Sci U S A. 2018;115(2):E283–91. doi:10.1073/pnas.1715112115.
   PubMed Web of Science ®Google Scholar
• Lu R, Wu S, Zhang Y, Xia Y, Zhou Z, Kato I, Dong H, Bissonnette M, Sun J. Salmonella protein AvrA activates the STAT3 signaling pathway in colon cancer. Neoplasia (New York, NY). 2016;18(5):307. doi:10.1016/j.neo.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Mughini-Gras L, Schaapveld M, Kramers J, Mooij S, Neefjes-Borst EA, van PW, Neefjes J. Increased colon cancer risk after severe Salmonella infection. PLOS ONE. [Internet]. 2018 [accessed 2023 Dec 8];13(1):e0189721. doi:10.1371/journal.pone.0189721.
   Web of Science ®Google Scholar
• Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, et al. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli. Nature. 2020;580(7802):269–273. doi:10.1038/s41586-020-2080-8.
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. doi:10.1038/nrmicro821.
   PubMed Web of Science ®Google Scholar
• Tomkovich S, Dejea CM, Winglee K, Drewes JL, Chung L, Housseau F, Pope JL, Gauthier J, Sun X, Mühlbauer M, et al. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic. J Clin Invest. 2019;129(4):1699–1712. doi:10.1172/JCI124196.
   PubMed Web of Science ®Google Scholar
• Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10(8):575–582. doi:10.1038/nrmicro2819.
   PubMed Web of Science ®Google Scholar
• Johnson CH, Dejea CM, Edler D, Hoang LT, Santidrian AF, Felding BH, Ivanisevic J, Cho K, Wick EC, Hechenbleikner EM, et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 2015;21(6):891–897. doi:10.1016/j.cmet.2015.04.011.
   PubMed Web of Science ®Google Scholar
• Soler AP. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis. 1999;20(8):1425–1432. doi:10.1093/carcin/20.8.1425.
   PubMed Web of Science ®Google Scholar
• Tremblay W, Mompart F, Lopez E, Quaranta M, Bergoglio V, Hashim S, Bonnet D, Alric L, Mas E, Trouche D, et al. Cytolethal distending toxin promotes replicative stress leading to genetic instability transmitted to daughter cells. Front Cell Dev Biol. 2021;9:656795. doi:10.3389/fcell.2021.656795.
   Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède J-P. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA. 2010;107(25):11537–11542. doi:10.1073/pnas.1001261107.
   PubMed Web of Science ®Google Scholar
• Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, Sears CL, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA. 2011;108(37):15354–15359. doi:10.1073/pnas.1010203108.
   PubMed Web of Science ®Google Scholar
• Clay SL, Fonseca-Pereira D, Garrett WS. Colorectal cancer: the facts in the case of the microbiota. J Clin Invest. [Internet] 2022;132(4). [accessed 2023 Jul 18]. doi:10.1172/JCI155101.
   Web of Science ®Google Scholar
• Ternes D, Tsenkova M, Pozdeev VI, Meyers M, Koncina E, Atatri S, Schmitz M, Karta J, Schmoetten M, Heinken A, et al. The gut microbial metabolite formate exacerbates colorectal cancer progression. Nat Metab. 2022;4:458–475. doi:10.1038/s42255-022-00558-0.
   Google Scholar
• Zheng D-W, Dong X, Pan P, Chen K-W, Fan J-X, Cheng S-X, Zhang X-Z. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nat Biomed Eng. 2019;3(9):717–728. doi:10.1038/s41551-019-0423-2.
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-Cadherin/β-Catenin signaling via its FadA Adhesin. Cell Host Microbe. 2013;14(2):195–206. doi:10.1016/j.chom.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Brown DG, Rao S, Weir TL, O’Malia J, Bazan M, Brown RJ, Ryan EP. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016;4(1):11. doi:10.1186/s40170-016-0151-y.
   PubMedGoogle Scholar
• Lucas C, Barnich N, Nguyen NH. Microbiota, inflammation and colorectal cancer. Int J Mol Sci. 2017;18(6):1310. doi:10.3390/ijms18061310.
   PubMed Web of Science ®Google Scholar
• Binda C, Gibiino G, Coluccio C, Sbrancia M, Dajti E, Sinagra E, Capurso G, Sambri V, Cucchetti A, Ercolani G, et al. Biliary diseases from the microbiome perspective: how microorganisms could change the approach to benign and malignant diseases. Microorganisms. 2022;10(2):312. doi:10.3390/microorganisms10020312.
   PubMed Web of Science ®Google Scholar
• Crawford RW, Gibson DL, Kay WW, Gunn JS. Identification of a bile-induced exopolysaccharide required for Salmonella biofilm formation on gallstone surfaces. Infect Immun. 2008;76(11):5341–5349. doi:10.1128/IAI.00786-08.
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11(7):1034–1043. doi:10.1111/j.1462-5822.2009.01323.x.
   PubMed Web of Science ®Google Scholar
• Prouty AM, Schwesinger WH, Gunn JS. Biofilm formation and interaction with the surfaces of gallstones by Salmonella spp. Infect Immun. 2002;70(5):2640–2649. doi:10.1128/IAI.70.5.2640-2649.2002.
   PubMed Web of Science ®Google Scholar
• Nath G, Gulati AK, Shukla VK. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol. 2010;16:5395–5404. doi:10.3748/wjg.v16.i43.5395.
   PubMed Web of Science ®Google Scholar
• Fowler CC, Chang S-J, Gao X, Geiger T, Stack G, Galán JE. Emerging insights into the biology of typhoid toxin. Curr Opin Microbiol. 2017;35:70–77. doi:10.1016/j.mib.2017.01.012.
   PubMed Web of Science ®Google Scholar
• Pickett CL, Whitehouse CA. The cytolethal distending toxin family. Trends Microbiol. 1999;7(7):292–297. doi:10.1016/S0966-842X(99)01537-1.
   PubMed Web of Science ®Google Scholar
• Scuron MD, Boesze-Battaglia K, Dlakić M, Shenker BJ. The cytolethal distending toxin contributes to microbial virulence and disease pathogenesis by acting as a tri-perditious toxin. Front Cell Infect Microbiol. 2016;6:168. doi:10.3389/fcimb.2016.00168.
   PubMed Web of Science ®Google Scholar
• Thelestam M, Frisan T. Cytolethal distending toxins. Rev Physiol Biochem Pharmacol. 2004;152:111–133.
   PubMed Web of Science ®Google Scholar
• Di Domenico EG, Cavallo I, Pontone M, Toma L, Ensoli F. Biofilm producing Salmonella typhi: chronic colonization and development of gallbladder cancer. IJMS. 2017;18(9):1887. doi:10.3390/ijms18091887.
   Google Scholar
• Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol. 2000;95(3):784–787. doi:10.1111/j.1572-0241.2000.01860.x.
   PubMed Web of Science ®Google Scholar
• Kumar S, Kumar S, Kumar S. Infection as a risk factor for gallbladder cancer. J Surg Oncol. 2006;93(8):633–639. doi:10.1002/jso.20530.
   PubMed Web of Science ®Google Scholar
• Upadhayay A, Pal D, Kumar A. Salmonella typhi induced oncogenesis in gallbladder cancer: co-relation and progression. Adv Cancer Biol Metastasis. 2022;4:100032. doi:10.1016/j.adcanc.2022.100032.
   Google Scholar
• Gagnaire A, Nadel B, Raoult D, Neefjes J, Gorvel J-P. Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. Nat Rev Microbiol. 2017;15(2):109–128. doi:10.1038/nrmicro.2016.171.
   PubMed Web of Science ®Google Scholar
• Johnson R, Ravenhall M, Pickard D, Dougan G, Byrne A, Frankel G, Payne SM. Comparison of Salmonella enterica serovars typhi and typhimurium reveals typhoidal serovar-specific responses to bile. Infect Immun. 2018;86(3):e00490–17. doi:10.1128/IAI.00490-17.
   Web of Science ®Google Scholar
• Chen L, Gu L, Geng X, Xu G, Huang X, Zhu X. A novel cis antisense RNA AsfD promotes Salmonella enterica serovar typhi motility and biofilm formation. Microb Pathog. 2020;142:104044. doi:10.1016/j.micpath.2020.104044.
   Web of Science ®Google Scholar
• Zhao H, Li Y. Cancer metabolism and intervention therapy. Mol Biomed. 2021;2(1):5. doi:10.1186/s43556-020-00012-1.
   Google Scholar
• Sheng X, Wang W, Chen L, Zhang H, Zhang Y, Xu S, Xu H, Huang X. Mig-14 may contribute to Salmonella enterica serovar typhi resistance to polymyxin B by decreasing the permeability of the outer-membrane and promoting the formation of biofilm. Int J Med Microbiol. 2019;309(2):143–150. doi:10.1016/j.ijmm.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Walawalkar YD, Vaidya Y, Nayak V, Monack D. Response of Salmonella typhi to bile-generated oxidative stress: implication of quorum sensing and persister cell populations. Pathog Dis. 2016;74(8):ftw090. doi:10.1093/femspd/ftw090.
   Web of Science ®Google Scholar
• Jesudhasan PR, Cepeda ML, Widmer K, Dowd SE, Soni KA, Hume ME, Zhu J, Pillai SD. Transcriptome analysis of genes controlled by luxS/autoinducer-2 in Salmonella enterica serovar Typhimurium. Foodborne Pathog Dis. 2010;7(4):399–410. doi:10.1089/fpd.2009.0372.
   Web of Science ®Google Scholar
• Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–270. doi:10.1038/nrg3182.
   PubMed Web of Science ®Google Scholar
• Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science. 2012;336(6086):1255–1262. doi:10.1126/science.1224203.
   PubMed Web of Science ®Google Scholar
• Bebek G, Bennett KL, Funchain P, Campbell R, Seth R, Scharpf J, Burkey B, Eng C. Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Hum Mol Genet [Internet]. 2012;21: 1557–1565. doi:10.1093/hmg/ddr593.
   Web of Science ®Google Scholar
• Frank DN, Qiu Y, Cao Y, Zhang S, Lu L, Kofonow JM, Robertson CE, Liu Y, Wang H, Levens CL, et al. A dysbiotic microbiome promotes head and neck squamous cell carcinoma. Oncogene. 2022;41(9):1269–1280. doi:10.1038/s41388-021-02137-1.
   Web of Science ®Google Scholar
• Marttila E, Uittamo J, Rusanen P, Lindqvist C, Salaspuro M, Rautemaa R. Acetaldehyde production and microbial colonization in oral squamous cell carcinoma and oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(1):61–68. doi:10.1016/j.oooo.2013.02.009.
   Web of Science ®Google Scholar
• Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, de Vallée A, Déchelotte P, Darcha C, Pezet D, Bonnet R, et al. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol. 2014;20:6560–6572. doi:10.3748/wjg.v20.i21.6560.
   PubMed Web of Science ®Google Scholar
• Cantero D, Cooksley C, Bassiouni A, Tran HB, Roscioli E, Wormald P-J, Vreugde S. Staphylococcus aureus biofilms induce apoptosis and expression of Interferon-γ, Interleukin-10, and Interleukin-17A on Human Sinonasal Explants. Am J Rhinol? Allergy. 2015;29(1):23–28. doi:10.2500/ajra.2015.29.4130.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee HK. Potential role of the gut microbiome in colorectal cancer progression. Front Immunol. 2022;12:807648. doi:10.3389/fimmu.2021.807648.
   Web of Science ®Google Scholar
• Curtis MA, Diaz PI, Van Dyke TE. The role of the microbiota in periodontal disease. Periodontol 2000. 2020;83:14–25. doi:10.1111/prd.12296.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lambris JD. Complement and dysbiosis in periodontal disease. Immunobiology. 2012;217(11):1111–1116. doi:10.1016/j.imbio.2012.07.007.
   Web of Science ®Google Scholar
• Yost S, Stashenko P, Choi Y, Kukuruzinska M, Genco CA, Salama A, Weinberg EO, Kramer CD, Frias-Lopez J. Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses. Int J Oral Sci. 2018;10(4):32. doi:10.1038/s41368-018-0037-7.
   PubMedGoogle Scholar
• Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ. Communication among oral bacteria. Microbiol Mol Biol Rev. 2002;66(3):486–505. doi:10.1128/MMBR.66.3.486-505.2002.
   PubMed Web of Science ®Google Scholar
• Brennan CA, Garrett WS. Fusobacterium nucleatum — symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019;17(3):156–166. doi:10.1038/s41579-018-0129-6.
   PubMed Web of Science ®Google Scholar
• Nagy KN, Sonkodi I, Szöke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34(4):304–308. doi:10.1016/S1368-8375(98)80012-2.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu Y, Zheng HJ, Zhang CP. The oral microbiota may have influence on oral cancer. Front Cell Infect Microbiol. 2020;9:476. doi:10.3389/fcimb.2019.00476.
   PubMed Web of Science ®Google Scholar
• Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM, Johnson NW. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep. 2017;7(1):1834. doi:10.1038/s41598-017-02079-3.
   PubMed Web of Science ®Google Scholar
• Zhao H, Chu M, Huang Z, Yang X, Ran S, Hu B, Zhang C, Liang J. Variations in oral microbiota associated with oral cancer. Sci Rep. 2017;7(1):11773. doi:10.1038/s41598-017-11779-9.
   PubMed Web of Science ®Google Scholar
• Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, Nussbaum G, Elkin M. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6(26):22613–22623. doi:10.18632/oncotarget.4209.
   PubMedGoogle Scholar
• Fardini Y, Wang X, Témoin S, Nithianantham S, Lee D, Shoham M, Han YW. Fusobacterium nucleatum adhesin FadA binds vascular-endothelial cadherin and alters endothelial integrity. Mol Microbiol. 2011;82:1468–1480. doi:10.1111/j.1365-2958.2011.07905.x.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Carioli G, Santucci C, Bertuccio P, Gallus S, Garavello W, Negri E, La Vecchia C. Global trends in oral and pharyngeal cancer incidence and mortality. Int J Cancer. 2020;147(4):1040–1049. doi:10.1002/ijc.32871.
   PubMed Web of Science ®Google Scholar
• Monti E, Barbara G, Libutti G, Boero V, Parazzini F, Ciavattini A, Bogani G, Pignataro L, Magni B, Merli C, et al. A clinician’s dilemma: what should be communicated to women with oncogenic genital HPV and their partners regarding the risk of oral viral transmission? BMC Women’s Health. 2022:22. doi:10.1186/s12905-022-01965-x
   Web of Science ®Google Scholar
• Andrews N, Griffiths C. Dental complications of head and neck radiotherapy: part 1. Aust Dent J. 2001;46(2):88–94. doi:10.1111/j.1834-7819.2001.tb00562.x.
   PubMed Web of Science ®Google Scholar
• Støre G, Eribe ERK, Olsen I. DNA–DNA hybridization demonstrates multiple bacteria in osteoradionecrosis. Int J Oral Max Surg. 2005;34(2):193–196. doi:10.1016/j.ijom.2004.06.010.
   Web of Science ®Google Scholar
• Curi MM, Dib LL, Kowalski LP, Landman G, Mangini C. Opportunistic actinomycosis in osteoradionecrosis of the jaws in patients affected by head and neck cancer: incidence and clinical significance. Oral Oncol. 2000;36(3):294–299. doi:10.1016/S1368-8375(99)00080-9.
   Web of Science ®Google Scholar
• Aas JA, Reime L, Pedersen K, Eribe ERK, Abesha-Belay E, Støre G, Olsen I. Osteoradionecrosis contains a wide variety of cultivable and non-cultivable bacteria. J Oral Microbiol. 2010;2:5072. doi:10.3402/jom.v2i0.5072.
   Google Scholar
• Li Z, Fu R, Huang X, Wen X, Zhang L. Oral microbiota may affect osteoradionecrosis following radiotherapy for head and neck cancer. J Transl Med. 2023;21(1):391. doi:10.1186/s12967-023-04219-y.
   Web of Science ®Google Scholar
• Tsai Y, Lin Y, Wu W, Chiu P, Lin BJ, Hao S. Biofilm formations in nasopharyngeal tissues of patients with nasopharyngeal osteoradionecrosis. Otolaryngol–Head Neck Surg. 2013;148:633–636. doi:10.1177/0194599812474971.
   Web of Science ®Google Scholar
• Conlon BP, Nakayasu ES, Fleck LE, MD L, Isabella VM, Coleman K, Leonard SN, Smith RD, Adkins JN, Lewis K. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 2013;503:365–370. doi:10.1038/nature12790.
   PubMed Web of Science ®Google Scholar
• Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med. 2013;64(1):175–188. doi:10.1146/annurev-med-042711-140023.
   PubMedGoogle Scholar
• Utsui Y, Yokota T. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1985;28(3):397–403. doi:10.1128/AAC.28.3.397.
   Web of Science ®Google Scholar
• Jiang R, Liu Y, Zhang H, Chen Y, Liu T, Zeng J, Nie E, Chen S, Tan J. Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma. Front Cell Infect Microbiol. 2022;12:1070322. doi:10.3389/fcimb.2022.1070322.
   Web of Science ®Google Scholar
• Gong H, Shi Y, Zhou X, Wu C, Cao P, Xu C, Hou D, Wang Y, Zhou L, Drake HL. Microbiota in the throat and risk factors for laryngeal carcinoma. Appl Environ Microbiol. 2014;80(23):7356–7363. doi:10.1128/AEM.02329-14.
   PubMed Web of Science ®Google Scholar
• Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. JCO. 2005;23(14):3175–3185. doi:10.1200/JCO.2005.10.462.
   PubMed Web of Science ®Google Scholar
• Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008;8(4):605–615. doi:10.1586/14737140.8.4.605.
   PubMed Web of Science ®Google Scholar
• Govindan R. Lung cancer in never smokers: a new hot area of research. Lancet Oncol. 2010;11(4):304–305. doi:10.1016/S1470-2045(10)70057-7.
   PubMed Web of Science ®Google Scholar
• Huang S. Mycoplasma infections and different human carcinomas. WJG. 2001;7:266. doi:10.3748/wjg.v7.i2.266.
   PubMed Web of Science ®Google Scholar
• Ushio S, Iwaki K, Taniai M, Ohta T, Fukuda S, Sugimura K, Kurimoto M. Metastasis-promoting activity of a novel molecule, Ag 243-5, derived from mycoplasma, and the complete nucleotide sequence. Microbiol Immunol. 1995;39(6):393–400. doi:10.1111/j.1348-0421.1995.tb02218.x.
   Web of Science ®Google Scholar
• Liu N-N, Ma Q, Ge Y, Yi C-X, Wei L-Q, Tan J-C, Chu Q, Li J-Q, Zhang P, Wang H. Microbiome dysbiosis in lung cancer: from composition to therapy. NPJ Precis Onc. 2020;4:33. doi:10.1038/s41698-020-00138-z.
   Web of Science ®Google Scholar
• Hwang SY, Kim JY, Lee HS, Lee S, Kim D, Kim S, Hyun JH, Shin JI, Lee KH, Han SH, et al. Pulmonary tuberculosis and risk of lung cancer: a systematic review and meta-analysis. J Clin Med. 2022;11(3):765. doi:10.3390/jcm11030765.
   Web of Science ®Google Scholar
• Chaturvedi AK, Gaydos CA, Agreda P, Holden JP, Chatterjee N, Goedert JJ, Caporaso NE, Engels EA. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidem Biomar. 2010;19(6):1498–1505. doi:10.1158/1055-9965.EPI-09-1261.
   Web of Science ®Google Scholar
• Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidem Biomar. 2005;14(4):773–778. doi:10.1158/1055-9965.EPI-04-0599.
   Web of Science ®Google Scholar
• Zhan P, Suo L, Qian Q, Shen X, Qiu L-X, Yu L, Song Y. Chlamydia pneumoniae infection and lung cancer risk: A meta-analysis. Eur J Cancer. 2011;47(5):742–747. doi:10.1016/j.ejca.2010.11.003.
   Web of Science ®Google Scholar
• Dancewicz M, Szymankiewicz M, Bella M, Swiniarska J, Kowalewski J. Bronchial bacterial colonization in patients with lung cancer. Pneumonol Alergol Pol. 2009;77(3):242–247. doi:10.5603/ARM.27802.
   Google Scholar
• Szymankiewicz M, Kowalewski J, Dancewicz M. [Bacteriological and mycological analysis of material taken from lower respiratory tract in patients with malignancy]. Pol Merkur Lekarski. 2006;21:218–222.
   Google Scholar
• Akshatha CR, Bhat S, Sindhu R, Shashank D, Rose Sommano S, Tapingkae W, Cheewangkoon R, Prasad SK. Current therapeutic options for gastric adenocarcinoma. Saudi J Biol Sci. 2021;28(9):5371–5378. doi:10.1016/j.sjbs.2021.05.060.
   PubMed Web of Science ®Google Scholar
• Shin WS, Xie F, Chen B, Yu P, Yu J, To KF, Kang W. Updated epidemiology of gastric cancer in Asia: decreased incidence but still a big challenge. Cancers Basel. 2023;15(9):2639. doi:10.3390/cancers15092639.
   Web of Science ®Google Scholar
• Sekiguchi M, Oda I, Matsuda T, Saito Y. Epidemiological trends and future perspectives of gastric cancer in Eastern Asia. Digestion. 2022;103(1):22–28. doi:10.1159/000518483.
   PubMed Web of Science ®Google Scholar
• Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol. 2017;15(12):740–755. doi:10.1038/nrmicro.2017.99.
   PubMed Web of Science ®Google Scholar
• Pucułek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget. 2018;9(57):31146–31162. doi:10.18632/oncotarget.25757.
   PubMedGoogle Scholar
• Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38. doi:10.5114/pg.2018.80001.
   PubMed Web of Science ®Google Scholar
• Carron MA, Tran VR, Sugawa C, Coticchia JM. Identification of Helicobacter pylori biofilms in human gastric mucosa. J Gastrointest Surg. 2006;10(5):712–717. doi:10.1016/j.gassur.2005.10.019.
   PubMed Web of Science ®Google Scholar
• Hsieh Y-Y, Tung S-Y, Pan H-Y, Yen C-W, Xu H-W, Lin Y-J, Deng Y-F, Hsu W-T, Wu C-S, Li C. Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci Rep. 2018;8(1):158. doi:10.1038/s41598-017-18596-0.
   PubMedGoogle Scholar
• Lehr K, Nikitina D, Vilchez-Vargas R, Steponaitiene R, Thon C, Skieceviciene J, Schanze D, Zenker M, Malfertheiner P, Kupcinskas J, et al. Microbial composition of tumorous and adjacent gastric tissue is associated with prognosis of gastric cancer. Sci Rep. 2023;13(1):4640. doi:10.1038/s41598-023-31740-3.
   Web of Science ®Google Scholar
• Abadi ATB. Strategies used by helicobacter pylori to establish persistent infection. World J Gastroenterol. 2017;23(16):2870–2882. doi:10.3748/wjg.v23.i16.2870.
   PubMed Web of Science ®Google Scholar
• Cellini L, Grande R, Di Campli E, Traini T, Di Giulio M, Nicola Lannutti S, Lattanzio R. Dynamic colonization of Helicobacter pylori in human gastric mucosa. Scand J Gastroenterol. 2008;43(2):178–185. doi:10.1080/00365520701675965.
   PubMed Web of Science ®Google Scholar
• Coticchia J, Sugawa C, Tran V, Gurrola J, Kowalski E, Carron M. Presence and density of helicobacter pylori biofilms in human gastric mucosa in patients with peptic ulcer disease. J Gastrointest Surg. 2006;10(6):883–889. doi:10.1016/j.gassur.2005.12.009.
   Web of Science ®Google Scholar
• Chan W-Y, Hui P-K, Leung K-M, Chow J, Kwok F, Ng C-S. Coccoid forms of Helicobacter pylori in the human stomach. Am J Clin Pathol. 1994;102(4):503–507. doi:10.1093/ajcp/102.4.503.
   Web of Science ®Google Scholar
• Zou Q, Zhang H, Meng F, He L, Zhang J, Xiao D, Chammas R. Proteomic and transcriptomic studies of BGC823 cells stimulated with Helicobacter pylori isolates from gastric MALT lymphoma. PLOS ONE. 2020;15(9):e0238379. doi:10.1371/journal.pone.0238379.
   Web of Science ®Google Scholar
• Valenzuela MA, Canales J, Corvalán AH, Quest AF. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J Gastroenterol. 2015;21:12742–12756. doi:10.3748/wjg.v21.i45.12742.
   PubMed Web of Science ®Google Scholar
• Huang F-Y, Chan A-O, Rashid A, Wong D-H, Cho C-H, Yuen M-F. Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1β activation of nitric oxide production in gastric cancer cells. Cancer. 2012;118:4969–4980. doi:10.1002/cncr.27519.
   PubMed Web of Science ®Google Scholar
• Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A, Annese V, Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol. 2007;102(7):1361–1371. doi:10.1111/j.1572-0241.2007.01284.x.
   Web of Science ®Google Scholar
• Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128–134. doi:10.1038/nrc.2017.118.
   PubMed Web of Science ®Google Scholar
• Sougleri IS, Papadakos KS, Zadik MP, Mavri-Vavagianni M, Mentis AF, Sgouras DN. Helicobacter pylori CagA protein induces factors involved in the epithelial to mesenchymal transition (EMT) in infected gastric epithelial cells in an EPIYA- phosphorylation-dependent manner. FEBS J. 2016;283(2):206–220. doi:10.1111/febs.13592.
   PubMed Web of Science ®Google Scholar
• Kay J, Thadhani E, Samson L, Engelward B. Inflammation-induced DNA damage, mutations and cancer. DNA Repair (Amst). 2019;83:102673. doi:10.1016/j.dnarep.2019.102673.
   PubMed Web of Science ®Google Scholar
• Perwez Hussain S, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121(11):2373–2380. doi:10.1002/ijc.23173.
   PubMed Web of Science ®Google Scholar
• Meng Z, Yang T. Liu DType-2 epithelial-mesenchymal transition in oral mucosal nonneoplastic diseases. Front Immunol [Internet]2022;13. doi:10.3389/fimmu.2022.1020768
   Web of Science ®Google Scholar
• Vergara D, Simeone P, Damato M, Maffia M, Lanuti P, Trerotola M. The cancer microbiota: EMT and inflammation as shared molecular mechanisms associated with plasticity and progression. J Oncol. 2019;2019:e1253727. doi:10.1155/2019/1253727.
   Web of Science ®Google Scholar
• Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015;15(1):38. doi:10.1186/s12935-015-0185-1.
   PubMed Web of Science ®Google Scholar
• Tomkovich S, Gharaibeh RZ, Dejea CM, Pope JL, Jiang J, Winglee K, Gauthier J, Newsome RC, Yang Y, Fodor AA, et al. Human colon mucosal biofilms and murine host communicate via altered mRNA and microRNA expression during cancer. MSystems. 2020;5:e00451–19. doi:10.1128/mSystems.00451-19.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.21387.
   PubMed Web of Science ®Google Scholar
• Vincent A, Hong S-M, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, et al. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget. 2014;5(9):2575–2587. doi:10.18632/oncotarget.1842.
   PubMedGoogle Scholar
• Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi:10.1158/0008-5472.CAN-14-0155.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015;6(9):7209–7220. doi:10.18632/oncotarget.3109.
   PubMedGoogle Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012: global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, Paster BJ, Joshipura K, Wong DTW. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61(4):582–588. doi:10.1136/gutjnl-2011-300784.
   PubMed Web of Science ®Google Scholar
• Alkharaan H, Lu L, Gabarrini G, Halimi A, Ateeb Z, Sobkowiak MJ, Davanian H, Fernández Moro C, Jansson L, Del Chiaro M, et al. Circulating and salivary antibodies to Fusobacterium nucleatum are associated with cystic pancreatic neoplasm malignancy. Front Immunol. 2020;11:2003. doi:10.3389/fimmu.2020.02003.
   PubMed Web of Science ®Google Scholar
• Karpiński TM. The microbiota and pancreatic cancer. Gastroenterol Clin North Am. 2019;48(3):447–464. doi:10.1016/j.gtc.2019.04.008.
   PubMed Web of Science ®Google Scholar
• Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres LE. et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403–416. doi:10.1158/2159-8290.CD-17-1134.
   PubMed Web of Science ®Google Scholar
• Half E, Keren N, Dorfman T, Reshef L, Lachter I, Kluger Y, Konikoff F, Gphna U. P-165 specific changes in fecal microbiota may differentiate pancreatic cancer patients from healthy individuals. Ann Oncol. 2015;26:iv48. doi:10.1093/annonc/mdv233.165.
   Web of Science ®Google Scholar
• Half E, Keren N, Reshef L, Dorfman T, Lachter I, Kluger Y, Reshef N, Knobler H, Maor Y, Stein A, et al. Fecal microbiome signatures of pancreatic cancer patients. Sci Rep. 2019;9(1):16801. doi:10.1038/s41598-019-53041-4.
   PubMed Web of Science ®Google Scholar
• Ren Z, Jiang J, Xie H, Li A, Lu H, Xu S, Zhou L, Zhang H, Cui G, Chen X, et al. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget. 2017;8(56):95176–95191. doi:10.18632/oncotarget.18820.
   PubMedGoogle Scholar
• Thomas RM, Gharaibeh RZ, Gauthier J, Beveridge M, Pope JL, Guijarro MV, Yu Q, He Z, Ohland C, Newsome R, et al. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models. Carcinogenesis. 2018;39(8):1068–1078. doi:10.1093/carcin/bgy073.
   PubMed Web of Science ®Google Scholar
• Mendez R, Kesh K, Arora N, Di Martino L, McAllister F, Merchant N, Banerjee S, Banerjee S. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer. Carcinogenesis. 2020;41(5):561–570. doi:10.1093/carcin/bgz116.
   PubMed Web of Science ®Google Scholar
• Corrales L, Matson V, Flood B, Spranger S, Gajewski TF. Innate immune signaling and regulation in cancer immunotherapy. Cell Res. 2017;27(1):96–108. doi:10.1038/cr.2016.149.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu D, Wang Q, Zheng D, Jiang X, Xu L. LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4. Dig Dis Sci. 2014;59(7):1452–1460. doi:10.1007/s10620-014-3049-y.
   Web of Science ®Google Scholar
• Santoni M, Andrikou K, Sotte V, Bittoni A, Lanese A, Pellei C, Piva F, Conti A, Nabissi M, Santoni G, et al. Toll like receptors and pancreatic diseases: from a pathogenetic mechanism to a therapeutic target. Cancer Treat Rev. 2015;41(7):569–576. doi:10.1016/j.ctrv.2015.04.004.
   PubMed Web of Science ®Google Scholar
• Yin H, Pu N, Chen Q, Zhang J, Zhao G, Xu X, Wang D, Kuang T, Jin D, Lou W, et al. Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer. Cell Death Disease. 2021;12(11):1033. doi:10.1038/s41419-021-04293-4.
   Web of Science ®Google Scholar
• Leung PS, Chan YC. Role of oxidative stress in pancreatic inflammation. Antioxid Redox Signal. 2009;11:135–165. doi:10.1089/ars.2008.2109.
   PubMed Web of Science ®Google Scholar
• Noureldein MH, Eid AA. Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction. Microb Pathog. 2018;118:98–104. doi:10.1016/j.micpath.2018.03.021.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang S, Dong S, Xu H, Zhou W. Association of the microbiota and pancreatic cancer: opportunities and limitations. Front Immunol. 2022;13:844401. doi:10.3389/fimmu.2022.844401.
   Web of Science ®Google Scholar
• Ma Y, Hao J. Dedifferentiation of epithelial cells incorporates immune reprogramming. Trends Cell Biol. 2021;31(4):237–240. doi:10.1016/j.tcb.2021.01.007.
   Web of Science ®Google Scholar
• Gnanasekaran J, Binder Gallimidi A, Saba E, Pandi K, Eli Berchoer L, Hermano E, Angabo S, Makkawi H, Khashan A, Daoud A, et al. Intracellular porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells. Cancers Basel. 2020;12(8):2331. doi:10.3390/cancers12082331.
   Google Scholar
• Chen S-M, Hsu L-J, Lee H-L, Lin C-P, Huang S-W, Lai C-L, Lin C-W, Chen W-T, Chen Y-J, Lin Y-C, et al. Lactobacillus attenuate the progression of pancreatic cancer promoted by Porphyromonas gingivalis in k-rasg12d transgenic mice. Cancers Basel. 2020;12:3522. doi:10.3390/cancers12123522.
   Web of Science ®Google Scholar
• Jiang Y, Geng M, Bai L. Targeting biofilms therapy: current research strategies and development hurdles. Microorganisms. 2020;8(8):1222. doi:10.3390/microorganisms8081222.
   Web of Science ®Google Scholar
• Huang X, Pan J, Xu F, Shao B, Wang Y, Guo X, Zhou S. Bacteria‐based cancer immunotherapy. Adv Sci (Weinh). 2021;8:2003572. doi:10.1002/advs.202003572.
   Google Scholar
• Soto Chervin C, Gajewski TF. Microbiome-based interventions: therapeutic strategies in cancer immunotherapy. Immunooncol Technol. 2020;8:12–20. doi:10.1016/j.iotech.2020.11.001.
   Google Scholar
• Srinivasan R, Santhakumari S, Poonguzhali P, Geetha M, Dyavaiah M, Xiangmin L. Bacterial biofilm inhibition: a focused review on recent therapeutic strategies for combating the biofilm mediated infections. Front Microbiol. 2021;12:676458. doi:10.3389/fmicb.2021.676458.
   PubMed Web of Science ®Google Scholar